Sunesis Pharmaceuticals (SNSS) Reports In-Line Q4 EPS

Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q4 EPS of ($0.19), in-line with the analyst estimate of ($0.19).

For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Stifel Reiterates Hold Rating on Nike (NKE)
• Kepler Cheuvreux Starts Swiss Re (SREN:SW) (SSREY) at Reduce